Home » Healthcare » Newborn Screening Market

Global Newborn Screening Market By Product Type (Instrument and Consumables), By Test Type (Blood test, Hearing screening test, and Heart screening) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 16266 | Report Format : PDF

Key Highlights of the report

How are the major segments performing in the Newborn Screening market?

  • In 2022, the consumables category accounted for the largest market share due to the ongoing need for consumables in newborn screening.
  • In 2022, the Blood test segment was anticipated to hold a prominent share in the global Newborn Screening market as the collection of blood from a newborn’s heel within 24-48 hours of delivery is referred to as a heel stick or dried blood spot test on the screening card for the identification of over 50 diseases (DBS).
  • In 2022, the Tandem Mass Spectrometry (TMS) segment accounted for the largest share of the market as it is utilized in laboratories capable of analyzing bodily fluids and other pollutants.
  • In 2022, the Hospitals segment was anticipated to hold a prominent share of the global Newborn Screening market. Hospitals highly prefer childbirth delivery, superior infrastructure, and modern methods.

Which region dominated the Newborn Screening market?

In 2022, the North American region was anticipated to hold a prominent share of the global Newborn Screening market. North America retained the biggest market share for newborn screening due to the increasing prevalence of congenital diseases and mandatory testing in all 50 states. The newborn screening program is rigorously implemented in all of North America’s states. To increase awareness, state health authorities in the United States have published free data and built websites designed to assist parents in coping with these diseases.

Newborn Screening Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

How US Market is Performing in the Newborn Screening market?

In 2022, the United States dominated the North American region. The adoption of non-invasive technology for newborn screening, attractive health reimbursement, and an increase in the frequency of preterm deliveries all contribute to expanding the market. According to the WHO, the United States is among the top 10 countries with the highest number of preterm births, with 517,400 preterm births in 2018. This is anticipated to promote the growth of the U.S. market for newborn screening.

How is the economy impacting the global Newborn Screening growth?

Due to the high rate of infectivity of the SARS-COV-2 virus, the COVID-19 pandemic touched every part of the global healthcare system. The screening procedures for newborns were also initially influenced by the diversion of resources to COVID-19 management, which is predicted to affect the market. According to a March 2022 study titled ‘Global impact of COVID-19 on newborn screening programs,’ the majority of newborn screening centers reported that the pandemic had little impact (47.7%), a moderate impact (18.6%), and a significant impact (12.2%), while 16.3% of the centers reported no impact. However, according to the same source, in 29 of the 38 nations that responded, COVID-19 had some effect on newborn screening programs. The majority of screening centers suffered various problems, with the second wave of the COVID affecting the majority more negatively. So, COVID-19 is anticipated to impact the market for newborn screening substantially.

What is the competitive environment of the Newborn Screening market?

The market for newborn screening is moderately competitive and comprises several large competitors. Regarding market share, a small number of market leaders now dominate the industry. In June 2022, the Rady Children’s Institute for Genomic Medicine launched an initiative to advance and evaluate the scalability of BeginNGS (pronounced “beginnings”), a diagnostic and precision medicine guidance tool designed to screen newborns for approximately 400 genetic conditions with known treatments using rapid whole genome sequencing. In February 2019, ArcherDX, Inc. disclosed its acquisition of Baby Genes, Inc., intending to expand its product range with newborn screening tests for spinal muscular atrophy, fragile X syndrome, and cystic fibrosis.

Executive Summary

What are the key trends in the Newborn Screening market?

  • According to the WHO, an estimated 15 million babies are born each year prematurely, which is growing exponentially. Diagnosis of the condition at birth is crucial for preserving the baby’s well-being. Newborn screening is a test or battery that helps discover potentially fatal or damaging illnesses that have a long-term impact on the child’s health and survival.
  • Market participants in newborn screening are releasing new and innovative products based on improved methodologies. This has allowed for a more precise and accurate diagnosis of infants with serious congenital cardiac disorders. Throughout the forecast period, innovations in point-of-care diagnostic equipment and an increased emphasis on early diagnosis are anticipated to enhance the global newborn screening market.

How is Growing Awareness for Screen of Newborn Babies Expected to Affect the Newborn Screening Market?

Screening newborns is essential for the early detection, diagnosis, and treatment of a disease or problem. Globally, around 7.9 million infants are born with significant congenital abnormalities each year, or approximately 6% of all births. (From Nature Journal). WHO estimates nine out of ten children with significant congenital anomalies are born in low- and middle-income countries. Heart problems, neural tube defects, and Down syndrome are some of the most frequent severe congenital malformations. It is estimated that between 0.8% and 1.2% of babies worldwide suffer from congenital cardiac disease. These congenital diseases are a leading cause of newborn death. According to the WHO, around 240,000 newborns die within 28 days of birth owing to congenital abnormalities each year. This market is anticipated to expand because of the increased frequency of numerous congenital abnormalities and the growing awareness among parents regarding newborn screening.

Which are the key investments by the Newborn Screening market players?

Increasing awareness of newborn screening is on the rise. Government and private market enterprises are investing in creating new tests and methodologies. As part of a three-year plan, the government will invest over £175 million in 2022 to improve the diagnosis of uncommon genetic illnesses in infants, cancer diagnostics, and health inequities.

Some major players in the Newborn Screening market are Ab Sciex LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Covidien Plc, Ge Healthcare, PerkinElmer, Inc., MASIMO CORPORATION, Natus Medical Incorporated, Trivitron Healthcare, and Waters Corporation.

What are the Major Driving Factors for the Newborn Screening Market?

The growth of the newborn screening market is driven by expanding newborn screening programs, rising rates of congenital illnesses, rising revenue from government sectors for newborn screening, and innovations in newborn screening technologies. In urban regions, the prevalence of congenital cardiovascular disease (CHD) has been 4.81 per 1,000 births from 2005 to 2020, compared to 3.17 per 1,000 births in rural areas. The prevalence of CHD increased by 157.45% and 316.03%, respectively, in urban and rural areas between 2005 and 2020, according to a study published in April 2022 titled “Epidemiology of Congenital Heart Disease in Jinan, China From 2005 to 2020: A Time Trend Analysis.” Moreover, the newborn screening programs administered by the government across the continent are anticipated to substantially affect the development of the newborn screening market, as numerous countries have mandated newborn screening before hospital release.

What are the Major Risks for the Newborn Screening Market?

Lack of development in healthcare facilities and a dearth of educated experts are the primary restraints on expanding the worldwide newborn screening market. For example, newborn screening is still not commonly practiced in Asia and requires further awareness and development. The nations of the Asia-Pacific area are rising economies with large populations and a limited number of qualified professionals. A large population of low- and middle-income earners and the poor quality of health services are impeding the improvement of health in Asian nations.

Which is the key test type in the Newborn Screening market?

Dried blood spot (DBS) tests are anticipated to maintain their dominance over the projection period. Since the 1960s, DBS sampling has been used to screen newborns for congenital metabolic disorders. The benefits of DBS sampling include modest volume requirements (about 30 to 100 L per spot), ease of sample acquisition via finger or heel stick with minimal training required, and convenience in transport and sample stability. This test can diagnose autism, lymphomas, leukemia, and many other metabolic diseases. Dried blood spot analysis provides the benefit of a small sample volume that is easily transportable. Consequently, increased infant mortality rates stimulate market expansion. In addition, only a few of firms and academic institutions in the market have developed new products and technologies to compete with the current offerings.

How is the Newborn Screening market performing in regions?

Asia Pacific market is anticipated to witness the fastest growth in the global Newborn Screening market during the forecast period. As a result of advantageous healthcare programs established by government agencies, the Asia-Pacific region is anticipated to experience lucrative expansion throughout the forecast period. In the past few years, awareness initiatives and quality assurance of newborn diagnostic techniques have gained relevance in the developing economies of South Korea, China, Taiwan, India, and Sri Lanka. Improved infrastructure and healthcare initiatives, as well as the availability of new expansion prospects, are anticipated to have a significant impact on demand over the projection period. In addition, Asia Pacific is anticipated to be the fastest-growing market for newborn screening procedures due to its high population density, increased birth rate, and skyrocketing prevalence of congenital disorders.

What is the regulatory landscape for the Newborn Screening market?

The purpose of the Screening for Heritable Disorders Law is to increase, improve, and extend the capacity of state and local public health organizations to provide screening, counseling, and health care services to newborns and children who have or are at risk for heritable diseases. This act formed the Heritable Disorders Program and the Advisory Council on Heritable Diseases in Newborns and Children (ACHDNC).

What is the Market Size of Newborn Screening regarding value?

The global Newborn Screening market is anticipated to grow at a substantial CAGR of 8.50% in the upcoming years. The global Newborn Screening industry was estimated to be worth USD 846.1 billion in 2022 and was expected to be worth USD 1497.71 billion by 2030.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the Newborn Screening market?

The expansion of the global newborn screening market is being fueled by the increasing number of newborns, heightened awareness of the unique specialty for infants, quick adoption of minimally invasive and non-invasive newborn screening procedures, and attractive health reimbursement. In addition, the increased prevalence of congenital cardiac diseases and genetic disorders among infants is predicted to fuel the global market for newborn screening. In addition, initiatives done by government and private organizations, as well as the development of new technologies, contribute to the expansion of the worldwide newborn screening market.

REPORT ATTRIBUTE DETAILS
Newborn Screening Market by Volume Yes
Newborn Screening Market by Value Yes
Newborn Screening Market, Tornado Analysis Yes
Newborn Screening Market, STAR Analysis Yes
Newborn Screening Market, SRC Analysis Yes
Newborn Screening Market, Import-Export Data Yes (On Demand)
Newborn Screening Market Pricing Analysis Yes (On Demand)
Newborn Screening Market Segment Analysis By Product Type (Instrument and Consumables)

By Test Type (Blood test, Hearing screening test, and Heart screening)

By Technology (Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays, Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, and Others)

By End User (Hospitals and Clinical laboratories)

Newborn Screening Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)

Newborn Screening Market Key Companies Ab Sciex LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Covidien Plc, Ge Healthcare, PerkinElmer, Inc., MASIMO CORPORATION, Natus Medical Incorporated, Trivitron Healthcare, and Waters Corporation
Newborn Screening Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Newborn Screening Market-

Global Newborn Screening Market – By Product Type

  • Instrument
  • Consumables

Global Newborn Screening Market – By Test Type

  • Blood test
  • Hearing screening test
  • Heart screening

Global Newborn Screening Market – By Technology

  • Tandem Mass Spectrometry (TMS)
  • Molecular Assays
  • Immunoassays and Enzymatic Assays
  • Hearing Screen Technology
  • Pulse Oximetry Screening Technology
  • Others

Global Newborn Screening Market – By End User

  • Hospitals
  • Clinical laboratories

Global Newborn Screening Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Newborn Screening Market
2.2. Global Newborn Screening Market, By Product Type
2.3. Global Newborn Screening Market, By Test Type
2.4. Global Newborn Screening Market, By Technology
2.5. Global Newborn Screening Market, By End User
2.6. Global Newborn Screening Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Newborn Screening Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Test Type
3.5.3. Technology
3.5.4. End User
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Product Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Newborn Screening Market
7.1. Global Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
7.1.1. Overview
7.1.2. Global Newborn Screening Market, By Product Type, 2022 vs 2030 (in%)
7.1.3. Global Newborn Screening Market, By Instrument, 2017-2030 (US$ Bn)
7.1.4. Global Newborn Screening Market, By Consumables, 2017-2030 (US$ Bn)
7.2. Global Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
7.2.1. Overview
7.2.2. Global Newborn Screening Market, By Product Type, 2022 vs 2030 (in%)
7.2.3. Global Newborn Screening Market, By Blood test, 2017-2030 (US$ Bn)
7.2.4. Global Newborn Screening Market, By Hearing screening test, 2017-2030 (US$ Bn)
7.2.5. Global Newborn Screening Market, By Heart screening, 2017-2030 (US$ Bn)
7.3. Global Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
7.3.1. Overview
7.3.2. Global Newborn Screening Market, By Technology, 2022 vs 2030 (in%)
7.3.3. Global Newborn Screening Market, Tandem Mass Spectrometry (TMS), 2017-2030 (US$ Bn)
7.3.4. Global Newborn Screening Market, Molecular Assays, 2017-2030 (US$ Bn)
7.3.5. Global Newborn Screening Market, Immunoassays and Enzymatic Assays, 2017-2030 (US$ Bn)
7.3.6. Global Newborn Screening Market, Hearing Screen Technology, 2017-2030 (US$ Bn)
7.3.7. Global Newborn Screening Market, Pulse Oximetry Screening Technology, 2017-2030 (US$ Bn)
7.3.8. Global Newborn Screening Market, Others, 2017-2030 (US$ Bn)
7.4. Global Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
7.4.1. Overview
7.4.2. Global Newborn Screening Market, By End User, 2022 vs 2030 (in%)
7.4.3. Global Newborn Screening Market, By Hospitals, 2017-2030 (US$ Bn)
7.4.4. Global Newborn Screening Market, By Clinical laboratories, 2017-2030 (US$ Bn)

8. North America Newborn Screening Market Analysis
8.1. North America Newborn Screening Market, by Product Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Newborn Screening Market, by Test Type, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Newborn Screening Market, by Technology, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Newborn Screening Market, by End User, 2017-2030(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
8.5.1. U.S.
8.5.1.1. U.S. Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.5.1.2. U.S. Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
8.5.1.3. U.S. Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
8.5.1.4. U.S. Newborn Screening, By Technology, 2017-2030 (US$ Bn)
8.5.1.5. U.S. Newborn Screening, By End User, 2017-2030 (US$ Bn)
8.5.2. Canada
8.5.2.1. Canada Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.5.2.2. Canada Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
8.5.2.3. Canada Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
8.5.2.4. Canada Newborn Screening, By Technology, 2017-2030 (US$ Bn)
8.5.2.5. Canada Newborn Screening, By End User, 2017-2030 (US$ Bn)

9. Europe Newborn Screening Market Analysis
9.1. Europe Newborn Screening Market, by Product Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Newborn Screening Market, by Test Type, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Newborn Screening Market, by Technology, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Newborn Screening Market, by End User, 2017-2030(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
9.5.1. Germany
9.5.1.1. Germany Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.1.2. Germany Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.1.3. Germany Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.1.4. Germany Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.1.5. Germany Newborn Screening, By End User, 2017-2030 (US$ Bn)
9.5.2. France
9.5.2.1. France Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.2.2. France Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.2.3. France Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.2.4. France Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.2.5. France Newborn Screening, By End User, 2017-2030 (US$ Bn)
9.5.3. UK
9.5.3.1. UK Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.3.2. UK Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.3.3. UK Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.3.4. UK Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.3.5. UK Newborn Screening, By End User, 2017-2030 (US$ Bn)
9.5.4. Italy
9.5.4.1. Italy Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.4.2. Italy Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.4.3. Italy Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.4.4. Italy Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.4.5. Italy Newborn Screening, By End User, 2017-2030 (US$ Bn)
9.5.5. Spain
9.5.5.1. Spain Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.5.2. Spain Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.5.3. Spain Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.5.4. Spain Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.5.5. Spain Newborn Screening, By End User, 2017-2030 (US$ Bn)
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.6.2. Rest of Europe Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
9.5.6.3. Rest of Europe Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
9.5.6.4. Rest of Europe Newborn Screening, By Technology, 2017-2030 (US$ Bn)
9.5.6.5. Rest of Europe Newborn Screening, By End User, 2017-2030 (US$ Bn)

10. Asia Pacific Newborn Screening Market Analysis
10.1. Asia Pacific Newborn Screening Market, by Product Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Newborn Screening Market, by Test Type, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Newborn Screening Market, by Technology, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Newborn Screening Market, by End User, 2017-2030(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
10.5.1. China
10.5.1.1. China Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.1.2. China Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.1.3. China Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.1.4. China Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.1.5. China Newborn Screening, By End User, 2017-2030 (US$ Bn)
10.5.2. Japan
10.5.2.1. Japan Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.2.2. Japan Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.2.3. Japan Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.2.4. Japan Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.2.5. Japan Newborn Screening, By End User, 2017-2030 (US$ Bn)
10.5.3. India
10.5.3.1. India Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.3.2. India Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.3.3. India Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.3.4. India Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.3.5. India Newborn Screening, By End User, 2017-2030 (US$ Bn)
10.5.4. South Korea
10.5.4.1. South Korea Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.4.2. South Korea Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.4.3. South Korea Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.4.4. South Korea Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.4.5. South Korea Newborn Screening, By End User, 2017-2030 (US$ Bn)
10.5.5. South-East Asia
10.5.5.1. South-East Asia Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.5.2. South-East Asia Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.5.3. South-East Asia Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.5.4. South-East Asia Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.5.5. South-East Asia Newborn Screening, By End User, 2017-2030 (US$ Bn)
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.6.2. Rest of Asia Pacific Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
10.5.6.3. Rest of Asia Pacific Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
10.5.6.4. Rest of Asia Pacific Newborn Screening, By Technology, 2017-2030 (US$ Bn)
10.5.6.5. Rest of Asia Pacific Newborn Screening, By End User, 2017-2030 (US$ Bn)

11. Latin America Newborn Screening Market Analysis
11.1. Latin America Newborn Screening Market, by Product Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Newborn Screening Market, by Test Type, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Newborn Screening Market, by Technology, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Newborn Screening Market, by End User, 2017-2030(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
11.5.1. Brazil
11.5.1.1. Brazil Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.1.2. Brazil Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
11.5.1.3. Brazil Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
11.5.1.4. Brazil Newborn Screening, By Technology, 2017-2030 (US$ Bn)
11.5.1.5. Brazil Newborn Screening, By End User, 2017-2030 (US$ Bn)
11.5.2. Mexico
11.5.2.1. Mexico Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.2.2. Mexico Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
11.5.2.3. Mexico Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
11.5.2.4. Mexico Newborn Screening, By Technology, 2017-2030 (US$ Bn)
11.5.2.5. Mexico Newborn Screening, By End User, 2017-2030 (US$ Bn)
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.3.2. Rest of Latin America Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
11.5.3.3. Rest of Latin America Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
11.5.3.4. Rest of Latin America Newborn Screening, By Technology, 2017-2030 (US$ Bn)
11.5.3.5. Rest of Latin America Newborn Screening, By End User, 2017-2030 (US$ Bn)

12. Middle East and Africa Newborn Screening Market Analysis
12.1. Middle East and Africa Newborn Screening Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Newborn Screening Market, by Test Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Newborn Screening Market, by Technology, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Newborn Screening Market, by End User, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
12.5.1. GCC Countries
12.5.1.1. GCC Countries Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.1.2. GCC Countries Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
12.5.1.3. GCC Countries Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
12.5.1.4. GCC Countries Newborn Screening, By Technology, 2017-2030 (US$ Bn)
12.5.1.5. GCC Countries Newborn Screening, By End User, 2017-2030 (US$ Bn)
12.5.2. South Africa
12.5.2.1. South Africa Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. South Africa Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
12.5.2.3. South Africa Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
12.5.2.4. South Africa Newborn Screening, By Technology, 2017-2030 (US$ Bn)
12.5.2.5. South Africa Newborn Screening, By End User, 2017-2030 (US$ Bn)
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Newborn Screening Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Rest of Middle East and Africa Newborn Screening, By Product Type, 2017-2030 (US$ Bn)
12.5.3.3. Rest of Middle East and Africa Newborn Screening, By Test Type, 2017-2030 (US$ Bn)
12.5.3.4. Rest of Middle East and Africa Newborn Screening, By Technology, 2017-2030 (US$ Bn)
12.5.3.5. Rest of Middle East and Africa Newborn Screening, By End User, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. Ab Sciex LLC.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Agilent Technologies Inc.
13.3. Bio-Rad Laboratories Inc.
13.4. Covidien Plc
13.5. Ge Healthcare
13.6. PERKINELMER, INC.
13.7. MASIMO CORPORATION
13.8. Natus Medical Incorporated
13.9. Trivitron Healthcare
13.10. Waters Corporation

List of Figures
FIG. 1 Global Newborn Screening Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Newborn Screening Market Segmentation
FIG. 4 Global Newborn Screening Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Newborn Screening Market, by Test Type, 2022 (US$ Bn)
FIG. 6 Global Newborn Screening Market, by Technology, 2022 (US$ Bn)
FIG. 7 Global Newborn Screening Market, by End User, 2022 (US$ Bn)
FIG. 8 Global Newborn Screening Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Product Type, 2022
FIG. 10 Attractive Investment Proposition, by Test Type, 2022
FIG. 11 Attractive Investment Proposition, by Technology, 2022
FIG. 12 Attractive Investment Proposition, by End User, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Newborn Screening Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Newborn Screening Market Manufacturers, 2022
FIG. 16 Global Newborn Screening Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 17 Global Newborn Screening Market, by Instrument, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Newborn Screening Market, by Consumables, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Newborn Screening Market Value Contribution, By Test Type, 2022 & 2030 (Value %)
FIG. 20 Global Newborn Screening Market, by Blood test, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Newborn Screening Market, by Hearing screening test, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Newborn Screening Market, by Heart screening, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Newborn Screening Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 24 Global Newborn Screening Market, Tandem Mass Spectrometry (TMS), Value, 2017-2030 (US$ Bn)
FIG. 25 Global Newborn Screening Market, Molecular Assays, 2017-2030 (US$ Bn)
FIG. 26 Global Newborn Screening Market, Immunoassays and Enzymatic Assays, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Newborn Screening Market, Hearing Screen Technology, 2017-2030 (US$ Bn)
FIG. 28 Global Newborn Screening Market, Pulse Oximetry Screening Technology, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Newborn Screening Market, Others, 2017-2030 (US$ Bn)
FIG. 30 Global Newborn Screening Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 31 Global Newborn Screening Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Newborn Screening Market, by Clinical laboratories, 2017-2030 (US$ Bn)
FIG. 33 North America Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 34 U.S. Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 35 Canada Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 36 Europe Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 37 Germany Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 38 France Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 39 U.K. Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 40 Italy Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 41 Spain Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 42 Rest of Europe Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 43 Asia Pacific Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 44 China Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 45 Japan Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 46 India Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 47 South Korea Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 48 South-East Asia Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Asia Pacific Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 50 Latin America Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 51 Brazil Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 52 Mexico Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Latin America Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 54 Middle East & Africa Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 55 GCC Countries Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 56 South Africa Newborn Screening Market, 2017-2030 (US$ Bn)
FIG. 57 Rest of Middle East and Africa Newborn Screening Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Newborn Screening Market
TABLE 2 Global Newborn Screening Market, by Competitive Benchmarking, 2022
TABLE 3 Global Newborn Screening Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Newborn Screening Market, by Key Strategies Analysis, 2022
TABLE 5 Global Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 6 Global Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 7 Global Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 8 Global Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 9 Global Newborn Screening Market, by Geography, 2017-2030 (US$ Bn)
TABLE 10 North America Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 11 North America Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 12 North America Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 13 North America Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 14 North America Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
TABLE 15 US Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 16 US Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 17 US Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 18 US Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 19 Canada Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 20 Canada Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 21 Canada Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 22 Canada Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 23 Europe Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 24 Europe Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 25 Europe Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 26 Europe Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 27 Europe Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
TABLE 28 Germany Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 29 Germany Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 30 Germany Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 31 Germany Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 32 France Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 33 France Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 34 France Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 35 France Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 36 UK Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 37 UK Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 38 UK Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 39 UK Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 40 Italy Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 41 Italy Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 42 Italy Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 43 Italy Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 44 Spain Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 45 Spain Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 46 Spain Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 47 Spain Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 48 Rest of Europe Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 49 Rest of Europe Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 50 Rest of Europe Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 51 Rest of Europe Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 52 Asia Pacific Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 53 Asia Pacific Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 54 Asia Pacific Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 55 Asia Pacific Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 56 Asia Pacific Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
TABLE 57 China Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 58 China Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 59 China Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 60 China Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 61 Japan Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 62 Japan Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 63 Japan Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 64 Japan Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 65 India Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 66 India Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 67 India Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 68 India Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 69 South Korea Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 70 South Korea Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 71 South Korea Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 72 South Korea Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 73 South-East Asia Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 74 South-East Asia Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 75 South-East Asia Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 76 South-East Asia Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 77 Rest of Asia Pacific Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 78 Rest of Asia Pacific Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 79 Rest of Asia Pacific Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 80 Rest of Asia Pacific Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 81 Latin America Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 82 Latin America Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 83 Latin America Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 84 Latin America Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 85 Latin America Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
TABLE 86 Brazil Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 87 Brazil Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 88 Brazil Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 89 Brazil Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 90 Mexico Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 91 Mexico Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 92 Mexico Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 93 Mexico Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 94 Rest of Latin America Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 95 Rest of Latin America Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 96 Rest of Latin America Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 97 Rest of Latin America Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 98 Middle East and Africa Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 99 Middle East and Africa Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 100 Middle East and Africa Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 101 Middle East and Africa Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 102 Middle East and Africa Newborn Screening Market, by Country, 2017-2030 (US$ Bn)
TABLE 103 GCC Countries Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 104 GCC Countries Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 105 GCC Countries Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 106 GCC Countries Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 107 South Africa Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 108 South Africa Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 109 South Africa Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 110 South Africa Newborn Screening Market, by End User, 2017-2030 (US$ Bn)
TABLE 111 Rest of Middle East and Africa Newborn Screening Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 112 Rest of Middle East and Africa Newborn Screening Market, by Test Type, 2017-2030 (US$ Bn)
TABLE 113 Rest of Middle East and Africa Newborn Screening Market, by Technology, 2017-2030 (US$ Bn)
TABLE 114 Rest of Middle East and Africa Newborn Screening Market, by End User, 2017-2030 (US$ Bn)

Frequently asked questions

How does COVID-19 Impact the global Newborn Screening market?

COVID-19 has impacted the economy in three primary ways: by altering production and demand, by disrupting distribution systems, and by having a monetary impact on businesses and financial markets. Several nations, including India, China, Saudi Arabia, Egypt, and the United Arab Emirates, are experiencing difficulties with drug shipment as a result of global lockdowns.

Which is the leading region of the market for Newborn screening?

North America accounted for the most heightened share in the global Newborn Screening market.

What are the key drivers for the growth of the Newborn Screening market?

The expansion of the newborn screening market can be attributed to expanding newborn screening programs, a rise in the frequency of congenital illnesses, an increase in government financing for newborn screening, and technological advancements in newborn screening equipment.

Which is the major segment in the Newborn Screening market by type?

The consumables chloride segment had a major share in the global market in 2022.

Which is the major segment in the Newborn Screening market by application?

The blood test segment had a major share in the global market.

United States Human Papillomavirus Vaccines Market

Published:
Report ID: 36384

White Canes Market

Published:
Report ID: 36378

Cancer Profiling Market

Published:
Report ID: 36289

Flowable Hemostats Market

Published:
Report ID: 36279

Fibrin Sealants Market

Published:
Report ID: 36276

Prostate Cancer Market

Published:
Report ID: 36273

ECG Telemetry Devices Market

Published:
Report ID: 36237

Blotting Systems Market

Published:
Report ID: 36233

India Dental Consumables Market

Published:
Report ID: 36214

Biotechnology and Pharmaceutical Services Outsourcing Market

Published:
Report ID: 36191

India Bariatric Surgery Devices Market

Published:
Report ID: 36164

Veterinary Imaging Systems Market

Published:
Report ID: 36104

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN